Sensex consolidates, Nifty above 10,000; pharma stock fall further
Equity benchmarks fell further for third consecutive session in opening Friday, weighed by healthcare stocks.
The 30-share BSE Sensex was down 43.68 points at 32,194.20 and the 50-share NSE Nifty fell 10 points to 10,003.65.
Sun Pharma, Dr Reddy's Labs, Lupin, Cipla, Aurobindo Pharma, Ambuja Cements, ONGC, Bharti Airtel, HDFC, Hero MotoCorp and Yes Bank declined up to 2 percent.
Biocon plunged 6 percent on getting 10 observations from USFDA for Bangalore plant
IOC, Tata Motors, BPCL, HUL, Tech Mahindra, Coal India, Axis Bank, Infosys, GAIL, HPCL and Wipro gained up to 2 percent.
Nifty Midcap was down 0.3 percent, dragged by pharma stocks. Cadila Healthcare, Strides, Torrent Pharma, Glenmark Pharma, MRF, Shree Pushkar, Titan, Kokoyu and Apollo Tyres fell up to 4 percent.
Asian markets wavered, after US stocks were dented overnight by a report that the special counsel investigation into Trump and his campaign was intensifying. Japan's Nikkei was down 0.4 percent while China's Shanghai gained 0.2 percent.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
Visit Here- http://www.capitalstars.com/
1 Comments
I really appreciate and often visit your blog. All the amendments and updates of global equity market are accurately mentioned in your articles in precise. This time too, the article is quite productive!! 24cfin is a research hub providing best equity tips. Avail for the
ReplyDeletefree trial now.
EQUITY TIPS